A Novel Bis-Spiroketal Scaffold and Other Secondary Metabolites from the Marine-Derived Fungus Talaromyces stipitatus HF05001: Structural Diversity and Bioactivities
Marine Drugs · 2026
DOI: 10.3390/md24010047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2026. Verfasst von Longhe Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Technical Innovation Center for Utilization of Marine Biological Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 36…. Hauptthemen laut MEDLINE: Talaromyces, Anti-Inflammatory Agents, Spiro Compounds, Furans. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Innovation Research and Development Special Funds of the Municipality-province-ministry Co-constructed, Scientific and Technological Projects of Fujian Province, People's Republic of China.
Abstract (Originalsprache)
Marine-derived fungi have become a vital resource for the discovery of novel secondary metabolites with diverse structures and significant biological activities. This study focuses on a systematic chemical investigation of the sponge-associated fungus Talaromyces stipitatus HF05001, leading to the isolation and identification of 20 compounds, including one new marine ketal natural product (Compound 17, Talarobispiral A). These compounds were structurally elucidated using comprehensive spectroscopic analyses, including 1D and 2D NMR, HRESIMS. All isolates were screened for their anti-inflammatory and anti-adipogenic properties. Among them, compound 4 (Secalonic acid D, SAD), 7 (Sch 725680) and 16 (bacillisporins C) demonstrated significant anti-inflammatory potential by markedly suppressing nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. Notably, compound 4 showed superior inhibitory effect, with an IC50 value of 0.22 μM. Additionally, compound 4 exhibited the strongest dose-dependent inhibition of lipid droplet accumulation in 3T3-L1 preadipocytes. These findings highlight the dual therapeutic potential of metabolites from Talaromyces stipitatus, identifying promising lead compounds for the development of novel treatments for inflammatory and metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Technical Innovation Center for Utilization of Marine Biological Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 361000, China.
- School of Medicine, Xiamen University, Xiamen 361102, China.
- Xiamen Key Laboratory of Chiral Drugs, Xiamen 361102, China.
ORCID-Profile: Yan Qiu
Förderung
- National Key Research and Development Program of China
- Innovation Research and Development Special Funds of the Municipality-province-ministry Co-constructed
- Scientific and Technological Projects of Fujian Province, People's Republic of China
- Scientific and Technological Projects of Fujian Province, People’s Republic of China
- Wu Jieping Medical Foundation
Zitieren
APA
Yang, L., Qiu, Y., Liu, Y., Wei, X., He, X., Wang, Y., Yan, Y., Bai, K., Wang, Z., & Ren, J. (2026). A Novel Bis-Spiroketal Scaffold and Other Secondary Metabolites from the Marine-Derived Fungus Talaromyces stipitatus HF05001: Structural Diversity and Bioactivities. Marine Drugs. https://doi.org/10.3390/md24010047
Vancouver
Yang L, Qiu Y, Liu Y, Wei X, He X, Wang Y, et al. A Novel Bis-Spiroketal Scaffold and Other Secondary Metabolites from the Marine-Derived Fungus Talaromyces stipitatus HF05001: Structural Diversity and Bioactivities. Marine Drugs. 2026. doi:10.3390/md24010047
BibTeX
@article{Yang2026,
author = {Yang, Longhe and Qiu, Yan and Liu, Ying and Wei, Xiaoyu and He, Xiwen and Wang, Yiling and Yan, Yajun and Bai, Kaikai and Wang, Zhaokai and Ren, Jie},
title = {A Novel Bis-Spiroketal Scaffold and Other Secondary Metabolites from the Marine-Derived Fungus Talaromyces stipitatus HF05001: Structural Diversity and Bioactivities},
journal = {Marine Drugs},
year = {2026},
doi = {10.3390/md24010047}
}
EUVIMED